Literature DB >> 10569940

Analysis of the AU-rich elements in the 3'-untranslated region of beta 2-adrenergic receptor mRNA by mutagenesis and identification of the homologous AU-rich region from different species.

B G Tholanikunnel1, J R Raymond, C C Malbon.   

Abstract

The 35000-Mr beta-adrenergic receptor mRNA binding protein (beta ARB) is induced by beta-adrenergic agonists and binds to G-protein-linked receptor mRNAs that exhibit agonist-induced destabilization. Recently, we identified a 20-nucleotide, AU-rich region in the 3'-untranslated region of the hamster beta 2-adrenergic receptor mRNA consisting of an AUUUUA hexamer flanked by U-rich regions, which constitutes the binding domain for beta ARB. U to G substitution in the hexamer region attenuates the binding of beta ARB, whereas U to G substitution of hexamer and flanking U-rich domains abolishes binding of beta ARB and stabilizes beta 2-adrenergic receptor mRNA levels in transfectant clones challenged with either isoproterenol or cyclic AMP. In the study presented here, we mutated the 20-nucleotide ARE region to establish the minimal AU-rich sequence required for beta ARB binding. U to G substitutions of flanking poly(U) regions and of the hexamer established the nature of the binding properties. Using various mutants, we demonstrated also that binding of beta ARB correlates with the extent of destabilization of beta 2-adrenergic receptor mRNA in response to agonist stimulation. High-affinity binding of hamster, rat, mouse, porcine, and human ARE sequences to beta ARB was revealed by SDS-polyacrylamide gel electrophoresis following UV-catalyzed cross-linking and by gel mobility shift assays. Further, beta ARB was shown to bind more avidly to the 20-nucleotide ARE region than to well-established mRNA destablization sequences of tandem repeats of five pentamers. Thus, for beta 2-adrenergic receptor, mRNA destabilization likely occurs via conserved AU-rich elements present in the 3'-untranslated regions of receptor mRNAs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10569940     DOI: 10.1021/bi9913348

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  The role of 3'-untranslated region (3'-UTR) mediated mRNA stability in cardiovascular pathophysiology.

Authors:  C M Misquitta; V R Iyer; E S Werstiuk; A K Grover
Journal:  Mol Cell Biochem       Date:  2001-08       Impact factor: 3.396

2.  Identification of Ebp1 as a component of cytoplasmic bcl-2 mRNP (messenger ribonucleoprotein particle) complexes.

Authors:  Sudeep K Bose; Tapas K Sengupta; Sumita Bandyopadhyay; Eleanor K Spicer
Journal:  Biochem J       Date:  2006-05-15       Impact factor: 3.857

3.  Sequence, haplotype, and association analysis of ADRbeta2 in a multiethnic asthma case-control study.

Authors:  Gregory A Hawkins; Kelan Tantisira; Deborah A Meyers; Elizabeth J Ampleford; Wendy C Moore; Barbara Klanderman; Stephen B Liggett; Stephen P Peters; Scott T Weiss; Eugene R Bleecker
Journal:  Am J Respir Crit Care Med       Date:  2006-08-24       Impact factor: 21.405

4.  CRM 1-mediated degradation and agonist-induced down-regulation of beta-adrenergic receptor mRNAs.

Authors:  Ying Bai; Huafei Lu; Curtis A Machida
Journal:  Biochim Biophys Acta       Date:  2006-08-22

5.  The 3'-untranslated region length and AU-rich RNA location modulate RNA-protein interaction and translational control of β2-adrenergic receptor mRNA.

Authors:  Kothandharaman Subramaniam; Karthikeyan Kandasamy; Kusumam Joseph; Eleanor K Spicer; Baby G Tholanikunnel
Journal:  Mol Cell Biochem       Date:  2011-03-03       Impact factor: 3.396

6.  Substrate dependence of conformational changes in the RNA-binding domain of tristetraprolin assessed by fluorescence spectroscopy of tryptophan mutants.

Authors:  Brandy Y Brewer; Jeff D Ballin; Elizabeth J Fialcowitz-White; Perry J Blackshear; Gerald M Wilson
Journal:  Biochemistry       Date:  2006-11-21       Impact factor: 3.162

7.  Variable-length poly-C tract polymorphisms of the beta2-adrenergic receptor 3'-UTR alter expression and agonist regulation.

Authors:  Alfredo Panebra; Mary Rose Schwarb; Steven M Swift; Scott T Weiss; Eugene R Bleecker; Gregory A Hawkins; Stephen B Liggett
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-11-16       Impact factor: 5.464

8.  Reciprocal regulation of beta-adrenergic receptor mRNA stability by mitogen activated protein kinase activation and inhibition.

Authors:  Violetta V Headley; Rasheeda Tanveer; Scott M Greene; Adam Zweifach; J David Port
Journal:  Mol Cell Biochem       Date:  2004-03       Impact factor: 3.396

9.  Effect of β2-adrenergic receptor gene (ADRB2) 3' untranslated region polymorphisms on inhaled corticosteroid/long-acting β2-adrenergic agonist response.

Authors:  Helen J Ambrose; Rachael M Lawrance; Carl J Cresswell; Mitchell Goldman; Deborah A Meyers; Eugene R Bleecker
Journal:  Respir Res       Date:  2012-05-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.